Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
about
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neuronsOxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventionsEdaravone guards dopamine neurons in a rotenone model for Parkinson's diseaseCardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonismPostnatal manganese exposure alters dopamine transporter function in adult rats: Potential impact on nonassociative and associative processesAutophagy as an essential cellular antioxidant pathway in neurodegenerative disease.Edaravone prevents neurotoxicity of mutant L166P DJ-1 in Parkinson's disease.Neuroprotective effects of umbelliferone and esculetin in a mouse model of Parkinson's disease.Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis.Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease.Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP.Knockdown of the mitochondria-localized protein p13 protects against experimental parkinsonism.Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage.
P2860
Q21262040-A365EB87-C7C6-4793-B23B-A7D605593932Q26851676-03487EF5-E016-4B39-95FF-8E6A860A115EQ27335848-C7D925E1-7866-4F70-B6E0-0E76E8CFB33DQ34061568-CB205FE1-569A-4972-9BA0-62E0F9CADEB4Q35587423-E326803B-4149-4193-9DF9-762B9B107A8CQ36839591-67EA72AA-635F-4A23-B51D-45AA80516876Q37539279-08CC1603-EC01-4578-8373-2C0A133F603DQ39154570-67E3B661-C942-417F-A168-169E533BF561Q39237644-15F0D1A1-3F92-42F5-9830-B263BDDB9474Q39240053-EE0CBF3B-F0F2-47B1-8164-FE8010EBB37EQ42175955-8EAC2173-1D51-4A77-ABF2-BAE73046A73FQ42483926-2B748A7D-A1C6-4FE3-9E5F-F16D1F9CF769Q47551783-0925F4C6-A0D7-49D0-A3E0-998131D4CDAEQ48706360-9C83E2C4-D4AD-43CB-AC4A-2A764A39F19C
P2860
Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@ast
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@en
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@nl
type
label
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@ast
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@en
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@nl
prefLabel
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@ast
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@en
Edaravone (3-methyl-1-phenyl-2 ...... ia nigra but not the striatum.
@nl
P2093
P921
P356
P1476
Edaravone (3-methyl-1-phenyl-2 ...... tia nigra but not the striatum
@en
P2093
Akemichi Baba
Kotaro Ishihara
Toshio Matsuda
Toshiyuki Kawasaki
P304
P356
10.1124/JPET.106.119206
P407
P50
P577
2007-04-11T00:00:00Z